Your browser doesn't support javascript.
loading
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.
Beckmann, Kerri; Garmo, Hans; Adolfsson, Jan; Bosco, Cecilia; Johansson, Eva; Robinson, David; Holmberg, Lars; Stattin, Par; Van Hemelrijck, Mieke.
Afiliação
  • Beckmann K; Australian Centre for Precision Health, University of South Australia, Adelaide, Australia; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. Electronic address: Kerri.beckmann@kcl.ac.uk.
  • Garmo H; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK; Regional Cancer Centre Uppsala, Uppsala University Hospital, Uppsala, Sweden.
  • Adolfsson J; Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
  • Bosco C; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Johansson E; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
  • Robinson D; Department of Urology, Ryhov Hospital, Jönköping, Sweden.
  • Holmberg L; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Stattin P; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
  • Van Hemelrijck M; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Eur Urol ; 75(4): 676-683, 2019 04.
Article em En | MEDLINE | ID: mdl-30497883
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Hormônio Liberador de Gonadotropina / Antineoplásicos Hormonais / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur Urol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Hormônio Liberador de Gonadotropina / Antineoplásicos Hormonais / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Eur Urol Ano de publicação: 2019 Tipo de documento: Article